scholarly journals Prevalence, Risk Factors, and Management of Prehypertension

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Wenwen Zhang ◽  
Ninghua Li

Prehypertension remains an important public health challenge all over the world and appropriate treatments should be adopted to prehypertensive group in different degree effectively. This review aimed to assess the prevalence of Prehypertension and provide effective evidence of the benefits of treating prehypertensive patients. The reasonable evaluation and appropriate intervention of prehypertensive remain need further study.

2020 ◽  
Vol 41 (4) ◽  
pp. 192
Author(s):  
Chris Lowbridge ◽  
Anna P Ralph

Tuberculosis (TB) remains an important public health challenge globally and in Australia. For the more than 10 million people who become sick with TB each year, the disease can cause immense personal and economic hardship, including loss of income and education through ill health, prolonged and arduous treatment, and stigmatisation – perpetuating a cycle of disadvantage. Past efforts to control TB have taught us much about modern disease control and public health. As the world grapples with the coronavirus (COVID-19) pandemic, the response to TB provides valuable lessons which can inform our response to COVID-19.


2015 ◽  
Vol 11 (1) ◽  
pp. 115
Author(s):  
Stephen H LaFranchi, MD ◽  

Despite the fact that programs began detecting neonates with congenital hypothyroidism (CH) over 40 years ago, at present only 30 % of the world birth population (approximately 127 million) undergoes screening for this disorder. The estimated cost of detection by screening, $15,400 compares with a lifetime expense of $1,296,000 in developed countries. The annual cost of the 30,000 CH cases not identified and treated early is approximately $40 billion dollars. Increasing the coverage of newborn screening worldwide remains a significant public health challenge.


2021 ◽  
pp. bjsports-2021-104527
Author(s):  
Benny Kai Guo Loo ◽  
Anthony David Okely ◽  
Aman Pulungan ◽  
Muhammad Yazid Jalaludin

Non-communicable diseases (NCDs) constitute a significant public health challenge and pose a great burden on health and social systems throughout the world. The Asia-Pacific region is in a vulnerable position as the prevalence of NCDs will inevitably increase with rapid socioeconomic transitions; yet it is ill prepared for this public health challenge as Asian children are among the most physically inactive in the world. Aligned with the WHO’s global strategy to control NCDs via preventive measures and health promotion policies, representatives from the Asia-Pacific region came together to develop consensus statement on integrated 24-hour activity guidelines for children and adolescents. These guidelines apply to children and adolescents, aged 5–18 years, in the Asia-Pacific region, regardless of gender, cultural background or socioeconomic status. These guidelines aim to provide the latest evidence-based recommendations, taking a holistic approach to lifestyle activities and adopting a practical perspective by framing these activities within a 24-hour period. Eating and dietary elements were incorporated as they closely influence the energy balance of the movement behaviours and vice versa. By investing in the younger generations through advocacy for healthier lifestyles, we aim to reduce the burden of NCDs in the Asia-Pacific region.


2020 ◽  
Vol 32 (4) ◽  
pp. 617-619
Author(s):  
Faruqueuddin Ahmed

Since the emergence of COVID 19 virus, scientists all over the world are working at breakneck speed to develop a vaccine. Development of a vaccine is not a competitive race to the finish as it must pass through a stringent process of evaluation. The process includes vaccines’ immunogenicity, duration of immunity, efficacy of protection, interaction with other antigens, dosage, route of administration, packaging, and thermostability and expected adverse events and safety. Efficacy of a new vaccine is measured in clinical trials under ideal conditions, whereas its effectiveness is measured in the field under actual program conditions. (1) In normal circumstances, vaccine development is a prolonged process, averaging over 10 years from start to finish (2). To meet the urgent, need a COVID 19 vaccine may be available in a much shorter-term frame, at the earliest in 18 months.


2021 ◽  
pp. 95-111
Author(s):  
David Rettew

Breastfeeding has made a huge comeback as its medical benefits became widely known—so much so that non-breastfeeding mothers often feel scorned and judged. Proponents of breastfeeding also contend that it makes children smarter and better behaved, and here is where the data get a little more complicated. This chapter will review the evidence that breastfeeding actually causes improved behavior and intelligence and examine the claims of some that these advantages are overstated. It will also explore an important “it depends” hypothesis that the developmental benefits of breastfeeding may be strongest for mothers who are less likely to do it in the first place—an interesting and important public health challenge.


Sign in / Sign up

Export Citation Format

Share Document